| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Research Communications |
1 From the Department of Medicine, The University of Western Australia and The West Australian Heart Research Institute, Perth.
Background: Obesity in hypertensive patients is associated with dyslipidemia and insulin resistance, both of which are improved by weight control. n-3 Fatty acids have diverse effects on mechanisms underlying atherosclerosis, including a decrease in serum triacylglycerols and an increase in HDL2 cholesterol.
Objective: The objective was to examine whether dietary fish enhances the effects of weight loss on serum lipids, glucose, and insulin in 69 overweight, treated hypertensive patients.
Design: Overweight patients being treated for hypertension were randomly assigned to either a daily fish meal (3.65 g n-3 fatty acids), a weight-loss regimen, the 2 regimens combined, or a control group for 16 wk.
Results: Sixty-three subjects completed the study. Weight decreased by a mean (±SEM) of 5.6 ± 0.8 kg with energy restriction. Weight loss decreased fasting insulin (P = 0.003) and the area under the curve for insulin (P = 0.003) and glucose (P = 0.047) during an oral-glucose-tolerance test. The greatest decrease occurred in the fish + weight-loss group. There was no independent effect of fish on glucose or insulin. Fish increased HDL2 cholesterol (P = 0.004) and decreased HDL3 cholesterol (P = 0.026) without altering total, LDL, or HDL cholesterol. Weight loss had no effect on these variables. Fasting triacylglycerols fell significantly with fish consumption (29%) and weight loss (26%). The fish + weight-loss group showed the greatest improvement in lipids: triacylglycerols decreased by 38% (P < 0.001) and HDL2 cholesterol increased by 24% (P = 0.04) compared with the control group.
Conclusions: Incorporating a daily fish meal into a weight-loss regimen was more effective than either measure alone at improving glucose-insulin metabolism and dyslipidemia. Cardiovascular risk is likely to be substantially reduced in overweight hypertensive patients with a weight-loss program incorporating fish meals rich in n-3 fatty acids.
Key Words: Fish • n-3 fatty acids • weight control • obesity • lipids • glucose • insulin • hypertension • humans
This article has been cited by other articles:
|
|
 |
|
  A. J Lucey, G. K Paschos, K. D Cashman, J A. Martinez, I. Thorsdottir, and M. Kiely Influence of moderate energy restriction and seafood consumption on bone turnover in overweight young adults Am. J. Clinical Nutrition, April 1, 2008; 87(4): 1045 - 1052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Hainer, H. Toplak, and A. Mitrakou Treatment Modalities of Obesity: What fits whom? Diabetes Care, February 1, 2008; 31(Supplement_2): S269 - S277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. De Caterina, R. Madonna, A. Bertolotto, and E. B. Schmidt n-3 Fatty Acids in the Treatment of Diabetic Patients: Biological rationale and clinical data Diabetes Care, April 1, 2007; 30(4): 1012 - 1026. [Full Text] [PDF]
|
|
|
|
|
|
J. D. Ard, S. C. Grambow, D. Liu, C. A. Slentz, W. E. Kraus, and L. P. Svetkey The Effect of the PREMIER Interventions on Insulin Sensitivity Diabetes Care, February 1, 2004; 27(2): 340 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Boyd Insulin and Cancer Integr Cancer Ther, December 1, 2003; 2(4): 315 - 329. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Erick Food Allergens and Blood Transfusions: A Cause for Concern? Arch Intern Med, August 11, 2003; 163(15): 1861 - 1861. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Ye, D. Zhang, C. Oltman, K. Dellsperger, H.-C. Lee, and M. VanRollins Cytochrome P-450 Epoxygenase Metabolites of Docosahexaenoate Potently Dilate Coronary Arterioles by Activating Large-Conductance Calcium-Activated Potassium Channels J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 768 - 776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Murase, A. Nagasawa, J. Suzuki, T. Wakisaka, T. Hase, and I. Tokimitsu Dietary {alpha}-Linolenic Acid-Rich Diacylglycerols Reduce Body Weight Gain Accompanying the Stimulation of Intestinal {beta}-Oxidation and Related Gene Expressions in C57BL/KsJ-db/db Mice J. Nutr., October 1, 2002; 132(10): 3018 - 3022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Murase, M. Aoki, T. Wakisaka, T. Hase, and I. Tokimitsu Anti-obesity effect of dietary diacylglycerol in C57BL/6J mice: dietary diacylglycerol stimulates intestinal lipid metabolism J. Lipid Res., August 1, 2002; 43(8): 1312 - 1319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Harper and T. A. Jacobson The Fats of Life: The Role of Omega-3 Fatty Acids in the Prevention of Coronary Heart Disease Arch Intern Med, October 8, 2001; 161(18): 2185 - 2192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Clarke Polyunsaturated Fatty Acid Regulation of Gene Transcription: A Molecular Mechanism to Improve the Metabolic Syndrome J. Nutr., April 1, 2001; 131(4): 1129 - 1132. [Abstract] [Full Text]
|
|
|
|
|
|
T. Murase, T. Mizuno, T. Omachi, K. Onizawa, Y. Komine, H. Kondo, T. Hase, and I. Tokimitsu Dietary diacylglycerol suppresses high fat and high sucrose diet-induced body fat accumulation in C57BL/6J mice J. Lipid Res., March 1, 2001; 42(3): 372 - 378. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. A. Mori, G. F. Watts, V. Burke, E. Hilme, I. B. Puddey, and L. J. Beilin Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Vascular Reactivity of the Forearm Microcirculation in Hyperlipidemic, Overweight Men Circulation, September 12, 2000; 102(11): 1264 - 1269. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
